BRIEF

on AFYREN (EPA:ALAFY)

AFYREN Signs Multi-Year Contract with US Nutraceutical Manufacturer

Stock price chart of AFYREN (EPA:ALAFY) showing fluctuations.

Clermont-Ferrand/Lyon, August 29, 2024 - AFYREN, a greentech company providing bio-based, low-carbon ingredients through unique fermentation technology, has finalized a commercial agreement with a US nutraceutical ingredients manufacturer.

The multi-year contract involves AFYREN supplying bio-based acids for use in preservatives and flavors for nutritional supplements. The nutraceuticals market, valued in the billions, is set for high-single-digit growth, driven by consumers' interest in natural and sustainable health products.

The US client, seeking alternatives to petro-based solutions, chose AFYREN for its natural fermentation process using traceable, non-food feedstock. The contract, initially based on limited volumes, may expand to larger quantities.

Nicolas Sordet, CEO of AFYREN, stated, “This contract demonstrates our ability to address specific markets with our unique value proposition, differentiating us from existing solutions.”

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all AFYREN news